The opioid overdose treatment market encompasses a range of pharmaceutical products designed to rapidly counteract life-threatening opioid toxicity. Key products include naloxone formulations such as intranasal sprays, auto-injectors and prefilled syringes, as well as emerging peptide-based antagonists and long-acting opioid receptor blockers. Opioid Overdose Treatment Market treatments offer critical advantages by restoring respiratory function, reducing coma risk, and minimizing hospital stays, thereby alleviating the burden on emergency medical services. Growing public health initiatives, increasing first-responder training, and expanded over-the-counter availability are fueling demand for user-friendly delivery systems. Moreover, advancements in drug design are improving bioavailability and onset time, while combination therapies aim to prevent relapse and enhance patient safety. As governments and multiple stakeholders intensify efforts to combat the opioid crisis, the need for scalable, cost-effective interventions drives research and development.

The Global Opioid Overdose Treatment Market is estimated to be valued at USD 48.79 Bn in 2025 and is expected to reach USD 74.83 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032.

Key Takeaways

Key players operating in the Opioid Overdose Treatment Market are

·         Enalare Therapeutics Inc.,

·         Opiant Pharmaceuticals,

·         Hikma Pharmaceuticals,

·         Emergent BioSolutions,

·         Purdue Pharma.

Enalare Therapeutics Inc. focuses on novel nasal delivery platforms to enhance patient outcomes and expand market share in emergency care settings. Opiant Pharmaceuticals leverages its proprietary peptide-based antagonists to address market gaps for long-acting treatments, complementing its strategic alliances with first responders. Hikma Pharmaceuticals, with its established global distribution network, accelerates product availability in emerging regions and collaborates on pricing models to increase affordability. Emergent BioSolutions concentrates on injectable and auto-injector solutions, investing in manufacturing capacity to meet growing demand. Purdue Pharma, despite regulatory scrutiny, continues to diversify its pipeline with combination therapies, aiming to capture opportunities in hospital and community pharmacy channels. Collectively, these market players drive innovation, shape market dynamics, and influence competitive intensity across regional segments.

Get More Insight On : Opioid Overdose Treatment Market

Get this Report in Japanese Language: オピオイド過剰摂取治療市場

Get this Report in Korean Language: 오피오이드과다복용치료시장